A. W. Galbraith

967 total citations
18 papers, 727 citations indexed

About

A. W. Galbraith is a scholar working on Epidemiology, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, A. W. Galbraith has authored 18 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 8 papers in Pediatrics, Perinatology and Child Health and 7 papers in Psychiatry and Mental health. Recurrent topics in A. W. Galbraith's work include Influenza Virus Research Studies (7 papers), Epilepsy research and treatment (7 papers) and Pharmacological Effects and Toxicity Studies (7 papers). A. W. Galbraith is often cited by papers focused on Influenza Virus Research Studies (7 papers), Epilepsy research and treatment (7 papers) and Pharmacological Effects and Toxicity Studies (7 papers). A. W. Galbraith collaborates with scholars based in United Kingdom and Switzerland. A. W. Galbraith's co-authors include D Chadwick, E. H. Reynolds, Simon Shorvon, J. S. Oxford, G. I. Watson, G. C. Schild, Edward Reynolds, John Gunn, C. W. Potter and W P Stephens and has published in prestigious journals such as The Lancet, The British Journal of Psychiatry and Epilepsia.

In The Last Decade

A. W. Galbraith

17 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. W. Galbraith United Kingdom	12	307	296	208	72	62	18	727
Hugh R. Butt United States	16	129 0.4×	127 0.4×	223 1.1×	38 0.5×	71 1.1×	33	892
Amit Gupta India	13	83 0.3×	71 0.2×	132 0.6×	40 0.6×	39 0.6×	56	1.0k
G. Salvia Italy	19	121 0.4×	65 0.2×	88 0.4×	16 0.2×	15 0.2×	30	993
R. Solà Spain	16	108 0.4×	145 0.5×	262 1.3×	16 0.2×	9 0.1×	69	897
I. Buttfield Australia	14	219 0.7×	63 0.2×	23 0.1×	20 0.3×	12 0.2×	25	781
Mert Küçük Türkiye	18	225 0.7×	85 0.3×	143 0.7×	28 0.4×	7 0.1×	73	848
Magnus Hjelm Sweden	14	88 0.3×	66 0.2×	71 0.3×	17 0.2×	29 0.5×	31	609
Sarah Jamali Lebanon	11	37 0.1×	56 0.2×	193 0.9×	50 0.7×	70 1.1×	20	598
J A Kuzemko United Kingdom	15	123 0.4×	35 0.1×	83 0.4×	10 0.1×	23 0.4×	43	767
S. Steinberg United States	9	129 0.4×	122 0.4×	111 0.5×	57 0.8×	4 0.1×	17	788

Countries citing papers authored by A. W. Galbraith

Since Specialization

Citations

This map shows the geographic impact of A. W. Galbraith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. W. Galbraith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. W. Galbraith more than expected).

Fields of papers citing papers by A. W. Galbraith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. W. Galbraith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. W. Galbraith. The network helps show where A. W. Galbraith may publish in the future.

Co-authorship network of co-authors of A. W. Galbraith

This figure shows the co-authorship network connecting the top 25 collaborators of A. W. Galbraith. A scholar is included among the top collaborators of A. W. Galbraith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. W. Galbraith. A. W. Galbraith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Galbraith, A. W.. (1985). INFLUENZA — RECENT DEVELOPMENTS IN PROPHYLAXIS AND TREATMENT. British Medical Bulletin. 41(4). 381–385. 2 indexed citations

Galbraith, A. W.. (1983). Prevention of Post‐Herpetic Neuralgia by Amantadine Hydrochloride (Symmetrel). International Journal of Clinical Practice. 37(9). 304–306. 26 indexed citations

Shorvon, Simon, A. W. Galbraith, M. Laundy, et al.. (1982). Chronic toxicity in epileptic patients receiving single-drug treatment. BMJ. 285(6339). 409–410. 19 indexed citations

Reynolds, E. H., et al.. (1981). Phenytoin Monotherapy for Epilepsy: A Long‐Term Prospective Study, Assisted by Serum Level Monitoring, in Previously Untreated Patients. Epilepsia. 22(4). 475–488. 37 indexed citations

Shorvon, Simon, D Chadwick, A. W. Galbraith, & E. H. Reynolds. (1978). One drug for epilepsy.. BMJ. 1(6111). 474–476. 125 indexed citations

Stephens, W P, M L Espir, R. B. Tattersall, et al.. (1977). Water intoxication due to carbamazepine.. BMJ. 1(6063). 754–755. 41 indexed citations

Reynolds, E. H., D Chadwick, & A. W. Galbraith. (1976). ONE DRUG (PHENYTOIN) IN THE TREATMENT OF EPILEPSY. The Lancet. 307(7966). 923–926. 86 indexed citations

Gunn, John, Edward Reynolds, D Chadwick, & A. W. Galbraith. (1976). ONE DRUG (PHENYTOIN) IN TREATMENT OF EPILEPSY. The Lancet. 308(7977). 150–150. 131 indexed citations

Galbraith, A. W.. (1975). Therapeutic trials of amantadine (Symmetrel) in general practice. Journal of Antimicrobial Chemotherapy. 1(suppl 4). 81–86. 9 indexed citations

10.

Galbraith, A. W., et al.. (1975). EXPERIENCES FROM PLANNING AND EXECUTION OF A CONTROLLED THERAPEUTIC TRIAL IN NEW CASES OF EPILEPSY. Acta Neurologica Scandinavica. 51. 75–76.

11.

Galbraith, A. W., et al.. (1974). A Double-Blind Study of Symmetrel (Amantadine Hydrochloride) in Parkinson's Disease. Journal of International Medical Research. 2(2). 137–141. 1 indexed citations

12.

Galbraith, A. W., G. C. Schild, C. W. Potter, & G. I. Watson. (1973). The therapeutic effect of amantadine in influenza occurring during the winter of 1971-2 assessed by double-blind study.. PubMed. 23(126). 34–7. 10 indexed citations

13.

Galbraith, A. W.. (1973). Treatment of Acute Herpes Zoster with Amantadine Hydrochloride (Symmetrel). BMJ. 4(5894). 693–695. 31 indexed citations

14.

Galbraith, A. W., J. S. Oxford, G. C. Schild, C. W. Potter, & G. I. Watson. (1971). THERAPEUTIC EFFECT OF 1-ADAMANTANAMINE HYDROCHLORIDE IN NATURALLY OCCURRING INFLUENZA A2/HONG KONG INFECTION. The Lancet. 298(7716). 113–115. 31 indexed citations

15.

Oxford, J. S., et al.. (1971). A study of 1-adamantamine hydrochloride during the 1970 Hong Kong influenza epidemic.. PubMed. 21(113). 695–7. 9 indexed citations

16.

Galbraith, A. W., J. S. Oxford, G. C. Schild, & G. I. Watson. (1969). Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment.. PubMed. 41(3). 677–82. 46 indexed citations

17.

Galbraith, A. W., J. S. Oxford, G. C. Schild, & G. I. Watson. (1969). PROTECTIVE EFFECT OF 1-ADAMANTANAMINE HYDROCHLORIDE ON INFLUENZA A2 INFECTIONS IN THE FAMILY ENVIRONMENT. The Lancet. 294(7629). 1026–1028. 77 indexed citations

18.

Galbraith, A. W., et al.. (1966). Tegretol (Carbamazepine): A Controlled Trial of a New Anti-Convulsant. The British Journal of Psychiatry. 112(488). 737–742. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact